Search

Your search keyword '"Ozdogu H"' showing total 173 results

Search Constraints

Start Over You searched for: Author "Ozdogu H" Remove constraint Author: "Ozdogu H"
173 results on '"Ozdogu H"'

Search Results

1. ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party

3. P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

4. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

6. Total body irradiation plus fludarabine compared to busulfan plus fludarabine as 'reduced-toxicity conditioning' for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

7. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

12. Daratumumab Monotherapy Among Heavily Pretreated Patients With

17. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

18. S114 POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMT

19. DISCOVERING ALTERNATIVE TARGETS IN CHRONIC MYELOID LEUKEMIA (CML): DETERMINATION OF EXPRESSION LEVELS OF BIOACTIVE SPHINGOLIPID GENES IN NEWLY DIAGNOSED AND DRUG-RESISTANT CML PATIENTS

20. EXPRESSION LEVELS OF JAK/STAT SIGNALING GENES IN NEWLY DIAGNOSED, DRUG SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS

24. EXPRESSION LEVELS OF CERAMIDE-GENERATING AND CLEARANCE GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS: AN ATTEMPT TO FIND NOVEL TARGETS

27. DIAGNOSTIC AND THERAPEUTIC POTENTIALS OF EXPRESSION LEVELS OF BIOACTIVE SPHINGOLIPID GENES IN NEWLY DIAGNOSED AND DRUG-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS

29. PP-062 EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML

49. Comparable outcomes using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: A study from IDWP and ALWP of the EBMT

Catalog

Books, media, physical & digital resources